Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 888-899

  Payne, Aimee S ^a   Ishii, Ken ^a   Kacir, Stephen ^a   Lin, Chenyan ^a   Li, Hong ^a   Hanakawa, Yasushi ^a   Tsunoda, Kazuyuki ^b   Amagai, Masayuki ^b   Stanley, John R ^a   Siegel, Don L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 1; DESMOGLEIN 3; EPITOPE; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; BLISTER; CELL CULTURE; DESMOSOME; DISSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; HEAVY CHAIN; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KERATINOCYTE; LIGHT CHAIN; MOUSE; NEWBORN; NONHUMAN; PATHOGENICITY; PEMPHIGUS VULGARIS; PHAGE DISPLAY; PRIORITY JOURNAL;

EID: 20144387052     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24185     Document Type: Article

References (54)

1. Payne, A.S., Hanakawa, Y., Amagai, M., and Stanley, J.R. 2004. Desmosomes and disease: pemphigus and bullous impetigo. Curr. Opin. Cell Biol. 16:536-543.
2. Ishii, K., et al. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159:2010-2017.
3. Ding, X., et al. 1997. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J. Invest. Dermatol. 109:592-596.
4. Amagai, M., Tsunoda, K., Zillikens, D., Nagai, T., and Nishikawa, T. 1999. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J. Am. Acad. Dermatol. 40:167-170.
5. Miyagawa, S., et al. 1999. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br. J. Dermatol. 141:1084-1087.
6. Amagai, M., Hashimoto, T., Shimizu, N., and Nishikawa, T. 1994. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59-67.
7. Amagai, M., Hashimoto, T., Green, K.J., Shimizu, N., and Nishikawa, T. 1995. Antigen-specific immunoabsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895-901.
8. Ding, X., Diaz, L.A., Fairley, J.A., Giudice, G.J., and Liu, Z. 1999. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J. Invest. Dermatol. 112:739-743.
9. Wu, H., et al. 2000. Protection of neonates against pemphigus foliaceus by desmoglein 3. N. Engl. J. Med. 343:31-35.
10. Shirakata, Y., Amagai, M., Hanakawa, Y., Nishikawa, T., and Hashimoto, K. 1998. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J. Invest. Dermatol. 110:76-78.
11. Mahoney, M.G., et al. 1999. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Invest. 103:461-468.
12. Wucherpfennig, K.W., et al. 1995. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc. Natl. Acad. Sci. U. S. A. 92:11935-11939.
13. Hacker-Foegen, M.K., Fairley, J. A., and Lin, M.S. 2003. T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris. J. Invest. Dermatol. 121:1365-1372.
14. Lin, M.S., et al. 1997. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J. Clin. Invest. 99:31-40.
15. Veldman, C., Höhne, A., Dieckmann, D., Schuler, G., and Hertl, M. 2004. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J. Immunol. 172:6468-6475.
16. Nishifuji, K., Amagai, M., Kuwana, M., Iwasaki, T., and Nishikawa, T. 2000. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J. Invest. Dermatol. 114:88-94.
17. Rock, B., Labib, R.S., and Diaz, L.A. 1990. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J. Clin. Invest. 85:296-299.
18. Mascaro, J.M., Jr., et al. 1997. Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin. Immunol. Immunopathol. 85:90-96.
19. Sekiguchi, M., et al. 2001. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J. Immunol. 167:5439-5448.
20. Li, N., Aoki, V., Hans-Filho, G., Rivitti, E.A., and Diaz, L.A. 2003. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J. Exp. Med. 197:1501-1510.
21. Tsunoda, K., et al. 2003. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J. Immunol. 170:2170-2178.
22. Amagai, M., et al. 2000. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J. Clin. Invest. 105:625-631.
23. Stein, L.D., and Sigal, N.H. 1983. Limiting dilution analysis of Epstein Barr virus-induced immunoglobulin production. Cell. Immunol. 79:309-319.
24. Roder, J.C., Cole, S.P., and Kozbor, D. 1986. The EBV-hybridoma technique. Methods Enzymol. 121:140-167.
25. Chang, T.Y., and Siegel, D.L. 1998. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood. 91:3066-3078.
26. Ishii, K., et al. 2005. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J. Invest. Dermatol. In press.
27. Kljuic, A., et al. 2003. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell. 113:249-260.
28. Kowalczyk, A.P., et al. 1995. Pemphigus sera recognize conformationally sensitive epicopes in the amino-terminal region of desmoglein-1 (Dsg1). J. Invest. Dermatol. 105:147-152.
29. Amagai, M., et al. 1995. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J. Invest. Dermatol. 105:243-247.
30. Collins, A.M., Sewell, W.A., and Edwards, M.R. 2003. Immunoglobulin gene rearrangement, repertoire diversity, and the allergic response. Pharmacol. Ther. 100:157-170.
31. Tindall, K.R., and Kunkel, T.A. 1988. Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry. 27:6008-6013.
32. Dörner, T., et al. 1998. Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire. J. Immunol. 160:2831-2841.
33. Futei, Y., et al. 2000. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J. Invest. Dermatol. 115:829-834.
34. Cook, G.P., and Tomlinson, I.M. 1995. The human immunoglobulin VH repertoire. Immunol. Today. 16:237-242.
35. Roark, J.H., Bussel, J.B., Cines, D.B., and Siegel, D.L. 2002. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood. 100:1388-1398.
36. Roben, P., et al. 1996. Repertoire cloning of lupus anti-DNA autoantibodies. J. Clin. Invest. 98:2827-2837.
37. Newkirk, M.M., et al. 1993. Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis. Mol. Immunol. 30:255-263.
38. Dörner, T., Hansen, A., Jacobi, A., and Lipsky, P.E. 2002. Immunoglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome. Autoimmun. Rev. 1:119-124.
39. Adderson, E.E., Shackelford, P.C., Quinn, A., and Carroll, W.L. 1991. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. 147:1667-1674.
40. Suzuki, I., Pfister, L., Glas, A., Nottenburg, C., and Milner, E.C.B. 1995. Representation of rearranged VH gene segments in the human adult antibody repertoire. J. Immunol. 154:3902-3911.
41. Kraj, P., et al. 1997. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J. Immunol. 158:5824-5832.
42. Roben, P., et al. 1996. Repertoire cloning of lupus anti-DNA autoantibodies. J. Clin. Invest. 98:2827-2837.
43. Goodyear, C.S., and Silverman, G.J. 2003. Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal toxin. J. Exp. Med. 197:1125-1139.
44. Silverman, G.J., Goodyear, C.S., and Siegel, D.L. 2005. On the mechanism of action of Staphylococcal protein A immunomodulation. Transfusion. 45:274-280.
45. Villard, S., et al. 2003. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor. Blood. 102:949-952.
46. Alvarado-Flores, E., Avalos-Diaz, E., Diaz, L.A., and Herrera-Esparza, R. 2001. Anti-idiotype antibodies neutralize in vivo the blistering effect of Pemphigus foliaceus IgG. Scand. J. Immunol. 53:254-258.
47. Grando, S.A., Pittelkow, M.R., Shultz, L.D., Dmochowski, M., and Nguyen, V.T. 2001. Pemphigus: an unfolding story. J. Invest. Dermatol. 117:990-994.
48. Barbas, C.F.I., Burton, D.R., Scott, J.K., and Silverman, G.J. 2001. Phage display: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 736 pp.
49. V BASE, http://vbase.mrc-cpe.cam.ac.uk. Medical Research Council Centre for Protein Engineering, University of Cambridge, Cambridge, United Kingdom.
50. Siegel, D.L., Chang, T.Y., Russell, S.L., and Bunya, V.Y. 1997. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology. J. Immunol. Methods. 206:73-85.
51. Amagai, M., Matsuyoshi, N., Wang, Z.H., Andl, C, and Stanley, J.R. 2000. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat. Med. 6:1275-1277.
52. Hanakawa, Y., et al. 2003. Calcium-dependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J. Invest. Dermatol. 121:383-389.
53. Amagai, M., Karpati, S., Prussick, R., Klaus-Kovtun, V., and Stanley, J.R. 1992. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:919-926.
54. Hanakawa, Y., et al. 2002. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J. Clin. Invest. 110:53-60. doi:10.1172/JCI20021S766.